UBS OCONNOR LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$5,520,000,000
+72.7%
5,810,0000.0%0.08%
+23.1%
Q4 2020$3,196,000,000
-26.6%
5,810,000
+9.4%
0.06%
-41.4%
Q3 2020$4,354,000,000
-4.7%
5,310,0000.0%0.11%
+9.9%
Q2 2020$4,567,000,000
+33.5%
5,310,000
+32.8%
0.10%
+44.3%
Q1 2020$3,420,000,000
-89.1%
4,000,000
-90.0%
0.07%
-92.0%
Q3 2019$31,402,000,000
-8.8%
40,000,0000.0%0.87%
+31.0%
Q2 2019$34,444,000,000
+311.8%
40,000,000
+300.0%
0.67%
+120.9%
Q4 2018$8,365,000,000
+881.8%
10,000,000
+900.0%
0.30%
+1913.3%
Q4 2017$852,000,000
-6.2%
1,000,0000.0%0.02%
+15.4%
Q3 2017$908,000,000
+5.2%
1,000,0000.0%0.01%
-7.1%
Q2 2017$863,000,000
-49.1%
1,000,000
-50.0%
0.01%
-51.7%
Q1 2017$1,697,000,000
-92.0%
2,000,000
-92.9%
0.03%
-93.0%
Q4 2016$21,345,000,000
+47.5%
28,000,000
+57.7%
0.41%
+91.6%
Q3 2016$14,467,000,00017,750,0000.22%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
LINDEN ADVISORS LP 15,510,000$16,119,0003.21%
GRACE BROTHERS MANAGEMENT LLC 2,500,000$2,592,0002.44%
Mohican Financial Management, LLC 3,000,000$3,113,0001.52%
Wellesley Asset Management 20,902$21,872,0001.36%
Fore Research & Management, LP 31,595,000$32,937,0000.97%
Man Investments (CH) AG 1,700,000$1,787,0000.93%
SYMPHONY ASSET MANAGEMENT LLC 7,834,000$8,128,0000.84%
BASSO CAPITAL MANAGEMENT, L.P. 5,000,000$5,150,0000.79%
Baker Brothers Advisors 60,000,000$62,050,0000.78%
CAMDEN ASSET MANAGEMENT L P /CA 10,225,000$10,608,0000.44%
View complete list of ACORDA THERAPEUTICS INC shareholders